Global Anticonvulsants Market Outlook: Trends, Innovations, and Forecasts
Anticonvulsants Market Overview Market Dynamics The global anticonvulsants market is witnessing steady growth driven by increasing prevalence of neurological disorders such as epilepsy, bipolar disorder, and neuropathic pain. Rising awareness, improving diagnosis rates, and growing geriatric population are contributing to the expansion of this market. However, side effects associated with long-term anticonvulsant use, generic competition, and stringent regulatory approvals may hinder growth to some extent. Valued at USD 19.2 billion in 2021, the global anticonvulsants market is projected to grow at a CAGR of 2.6% from 2022 to 2030, reaching an estimated USD 24.1 billion by the end of the forecast period. Regional Analysis North America leads the market owing to advanced healthcare infrastructure, strong R&D activities, and high prevalence of epilepsy. Europe follows closely with support from government-funded healthcare programs and research inc...